Skip to content
Screener

SANUWAVE Health, Inc. SNWV Q3 2025 earnings

Reported November 7, 2025 · Before market open

Revenue$11.5MMiss by $1.8M
EPS$0.46Beat by $0.14
Revenue estimate$13.2M
EPS estimate$0.32

Next report

Nov 6, 2026 (in 2 months)
Revenue estimate$13.8M
EPS estimate$0.01

Financials

Q3 2025

Income statement

See full
Revenue$11.3M+20.4%
Gross profit$8.7M+23.7%
Operating income$903.0K-39.1%
Net income$9.7M+146%
EPS (diluted)$0.39+106%

Balance sheet

See full
Cash & equivalents$9.6M+195%
Total debt$23.9M—
Total equity-$7.6M+87.4%
Total assets$35.6M+63.0%

Cash flow

See full
Operating cash flow$1.1M-15.7%
CapEx$525.0K+994%
Free cash flow$556.0K-54.9%

Valuation & ratios

Profitability

See full
Gross margin78.1%+5.3pp
Operating margin12.1%—
Net margin-22.3%—
FCF margin-1.9%—

Returns & leverage

See full
Current ratio0.9×+0.8×

Segments

By segment

See full
Reportable Segment$11.5M+22.3%

By product

See full
System revenue$4.4M—

FAQ

When did SANUWAVE Health, Inc. report Q3 2025 earnings?
SANUWAVE Health, Inc. (SNWV) reported Q3 2025 earnings on November 7, 2025 before market open.
What were SANUWAVE Health, Inc.'s Q3 2025 revenue and EPS?
SANUWAVE Health, Inc. reported revenue of $11.5M and eps of $0.46 for Q3 2025.
Did SANUWAVE Health, Inc. beat estimates in Q3 2025?
Revenue missed the consensus estimate of $13.2M by $1.8M. EPS beat the consensus estimate of $0.32 by $0.14.
How did SANUWAVE Health, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 22.3% from $9.4M a year earlier.
Where can I find SANUWAVE Health, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-050406) and the 10-Q periodic report (0001628280-25-050280) directly on SEC EDGAR. The filing index links above go to sec.gov.